REGENERON PHARMACEUTICALS INC

Federal contract awards won by REGENERON PHARMACEUTICALS INC (UEI N3F9MH7E6HD6), 2016–2021 — public record from USAspending.

Showing awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

5
awards
$6,551,995,881
total value
3
agencies

Agencies buying from REGENERON PHARMACEUTICALS INC

Department of Health and Human Services (3)Department of Defense (1)Department of Veterans Affairs (1)

What REGENERON PHARMACEUTICALS INC sells

541711 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (3)325412 — PHARMACEUTICAL PREPARATION MANUFACTURING (1)325414 — BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING (1)

Awards

EVKEEZA DRUG
Department of Veterans Affairs · $494,095 · Nov 24, 2021
PRODUCTION OF THERAPEUTIC IN SUPPORT OF NATIONAL EMERGENCY RESPONSE TO CORONAVIRUS 2019 (COVID-19): IN SUPPORT OF OPERATION WARP SPEED (OWS), THE GOVERNMENT IS PURCHASING UP TO 1,250,000 DOSES OF THE EMERGENCY USE AUTHORIZATION (EUA) THERAPEUTIC.
Department of Defense · $5,565,000,000 · Jan 12, 2021
IGF::OT::IGF
Department of Health and Human Services · $693,056,927 · Sep 30, 2017
IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD
Department of Health and Human Services · $284,843,230 · Sep 21, 2017
IGF::OT::IGF
Department of Health and Human Services · $8,601,629 · Aug 9, 2016

Researching this competitor? BidCatch doesn't just show you what they won — it sends you the open bids in your trade every morning, before they're awarded. Free for 14 days, then $49.99/month.

Search open bids